Thought Leadership

Texas Round-Up: May 2025

The PREVAIL Act Is Back. Will It Prevail This Time?

Federal Circuit Reverses Injunction That Barred Clinical Trials in Jazz v. Avadel

Expert Testimony in an Era of Skepticism of Expertise

Navigating Change at the USPTO

En Banc Federal Circuit Grants Google a New Trial in EcoFactor  Case 

John Squires Faces the Senate Judiciary Committee  

HHS Sets Most-Favored-Nation Price Targets for Pharmaceuticals 

Acting USPTO Director Stewart Issues First Decisions Under Interim Discretionary Denial Process

No Space at the Trademark Office for US SPACE FORCE

How Trump’s Latest Drug Price EO Could Impact Pharma

Patent Diligence for VCs and PEs